[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Neurology Devices Market Analysis By Product (Neurostimulation, Interventional Neurology, CSF Management, Spinal Cord Stimulation, Deep Brain Stimulation, Embolization, Neurovascular Catheters, Cerebral Angioplasty & Stents, CSF Shunts, Ultrasonic Aspirators, Stereotactic Systems) And Segment Forecasts To 2022

August 2014 | 87 pages | ID: N694D39984FEN
Grand View Research, Inc.

US$ 5,950.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
Global neurology devices market is expected to reach USD 10.8 billion by 2022, according to a new report by Grand View Research, Inc. This expected growth in demand can be ascribed to growing need for development of different neurostimulation techniques with efficient and accurate algorithms for treatment of several CNS associated disorders.

Rise in incidence of cerebral stroke and other severe disorders such as Alzheimer’s disease, epilepsy, and Parkinsonism is expected to fuel demand of neurology devices thereby driving industry growth. According to National Institute of Neurological Disorders and Stroke (NINDS), approximately 50 million Americans are affected due to these disorders leading to high economic & disease costs burden for medical expenses coupled with loss of productivity. The industry is expected to witness a considerable increase in demand for CNS related therapeutic procedures over the forecast period.

Further key findings from the study suggest:

Neurostimulation devices accounted for over 50% of the revenue generated in the market for 2014. This large share can be attributed to the growing number of chronic CNS disorders, a globally ageing population and development of minimally invasive neurological and faster acting stimulation devices that attract higher market usage and penetration in the neurology devices market.

Neurosurgery segment including ultrasonic aspirators, stereotactic systems, neuroendoscopes, and aneurysm clips are expected to witness considerable growth over the forecast period due to their essential nature of use in tumor removal and brain cell damage repair surgeries.

North America dominated the market in 2014, with revenue estimated at over USD 2,400 million. Presence of sophisticated healthcare infrastructure, favorable government initiatives pertaining to pharmaceutical R&D, cancer research, neurological R&D investment, and the presence of a considerably large CNS disorder patient base are some drivers of this market.

Asia Pacific is expected to witness lucrative CAGR of over 8.0% from 2015 to 2022 due to the presence of high-unmet medical needs coupled with rapidly rising healthcare R&D investment, and growing medical expenditures in emerging economies such as India and China. Supportive government initiatives pertaining to increasing investments by manufacturers and governments in neuro-informatics and high untapped market opportunities are the important factors accounting for the expected growth of market in this region over the forecast period.

Key participants of the neurology devices market include Johnson and Johnson, B.Braun Melsungen AG, Boston Scientific Corporation, St. Jude Medical Inc Covidien PLC, Medtronic Inc., Johnson & Johnson, Magstim Co Ltd., W.L. Gore & Associates Inc., Integra Life Sciences Holdings Corp., Stryker Corp.

Market participants are involved in R&D for development of advanced stimulation and neuromodulation techniques with minimally invasive procedures that are more preferable to the patients. Furthermore, collaborations with university as well as non-university based institutes that are engaged in neuroscience research are expected to boost sector growth in the coming years.
CHAPTER 1 METHODOLOGY AND SCOPE

1.1 Research Methodology
1.2 Research Scope & Assumptions
1.3 List of Data Sources

CHAPTER 2 EXECUTIVE SUMMARY

CHAPTER 3 NEUROLOGY DEVICES INDUSTRY OUTLOOK

3.1 Market segmentation
3.2 Market size and growth prospects, 2012 - 2022
3.3 Neurology devices market dynamics
  3.3.1 Market driver analysis
    3.3.1.1 Technological advances driving growth
    3.3.1.2 Growing base of aging population more prone to chronic diseases such as Parkinson’s and Alzheimer’s disorders
    3.3.1.3 Increasing demand for minimally invasive surgeries
    3.3.1.4 Rising number of stroke patients
  3.3.2 Market restraint analysis
    3.3.2.1 Rising intricacies of clinical trials
    3.3.2.2 Hospital budget constraints & alternative treatment facilities
3.4 Key opportunities prioritized, 2014
3.5 Industry analysis - Porter’s
3.6 Neurology devices PESTEL Analysis

CHAPTER 4 NEUROLOGY DEVICES PRODUCT OUTLOOK

4.1 Global neurology devices revenue share, by product, 2014 & 2022
4.2 Neurostimulation
  4.2.1 Neurostimulation market, 2012 - 2022 (USD Million)
  4.2.2 Spinal cord stimulation devices
    4.2.2.1 Spinal cord stimulation devices market, 2012 - 2022 (USD Million)
  4.2.3 Deep brain stimulation devices
    4.2.3.1 Deep brain stimulation devices market, 2012 - 2022 (USD Million)
  4.2.4 Sacral nerve stimulation
    4.2.4.1 Sacral nerve stimulation market, 2012 - 2022 (USD Million)
  4.2.5 Vagus nerve stimulation
    4.2.5.1 Vagus nerve stimulation market, 2012 - 2022 (USD Million)
  4.2.6 Gastric electric stimulation
    4.2.6.1 Gastric electric stimulation market, 2012 - 2022 (USD Million)
4.3 Interventional neurology
  4.3.1 Interventional neurology market, 2012 - 2022 (USD Million)
  4.3.2 Aneurysm coiling & embolization
    4.3.2.1 Aneurysm coiling & embolization market, 2012 - 2022 (USD Million)
    4.3.2.2 Embolic coils
      4.3.2.2.1 Embolic coils market, 2012 - 2022 (USD Million)
    4.3.2.3 Flow diversion devices
      4.3.2.3.1 Flow diversion devices market, 2012 - 2022 (USD Million)
    4.3.2.4 Liquid embolic agents
      4.3.2.4.1 Liquid embolic agents market, 2012 - 2022 (USD Million)
  4.3.3 Neurovascular catheters
    4.3.3.1 Neurovascular catheters market, 2012 - 2022 (USD Million)
    4.3.3.2 Micro catheters
      4.3.3.2.1 Micro catheters market, 2012 - 2022 (USD Million)
    4.3.3.3 Micro guide wires
      4.3.3.3.1 Micro guide wires market, 2012 - 2022 (USD Million)
  4.3.4 Cerebral balloon angioplasty & stenting
    4.3.4.1 Cerebral balloon angioplasty & stenting market, 2012 - 2022 (USD Million)
    4.3.4.2 Carotid artery stents
      4.3.4.2.1 Carotid artery stents market, 2012 - 2022 (USD Million)
    4.3.4.3 Filter devices
      4.3.4.3.1 Filter devices market, 2012 - 2022 (USD Million)
    4.3.4.4 Balloon occlusion devices
      4.3.4.4.1 Balloon occlusion devices market, 2012 - 2022 (USD Million)
  4.3.5 Neurothrombectomy
    4.3.5.1 Neurothrombectomy market, 2012 - 2022 (USD Million)
    4.3.5.2 Clot retriever
      4.3.5.2.1 Clot retriever market, 2012 - 2022 (USD Million)
    4.3.5.3 Suction aspiration devices
      4.3.5.3.1 Suction aspiration devices market, 2012 - 2022 (USD Million)
    4.3.5.4 Snares
      4.3.5.4.1 Snares market, 2012 - 2022 (USD Million)
4.4 CSF management
  4.4.1 CSF management market, 2012 - 2022 (USD Million)
  4.4.2 CSF shunts
    4.4.2.1 CSF shunts devices market, 2012 - 2022 (USD Million)
  4.4.3 CSF drainage
    4.4.3.1 CSF drainage market, 2012 - 2022 (USD Million)
4.5 Neurosurgery devices
  4.5.1 Neurosurgery devices market, 2012 - 2022 (USD Million)
  4.5.2 Ultrasonic aspirators
    4.5.2.1 Ultrasonic aspirators devices market, 2012 - 2022 (USD Million)
  4.5.3 Stereotactic systems
    4.5.3.1 Stereotactic systems market, 2012 - 2022 (USD Million)
  4.5.4 Neuroendoscopes
    4.5.4.1 Neuroendoscopes market, 2012 - 2022 (USD Million)
  4.5.5 Aneurysm clips
    4.5.5.1 Aneurysm clips market, 2012 - 2022 (USD Million)

CHAPTER 5 NEUROLOGY DEVICES REGIONAL OUTLOOK

5.1 Neurology devices revenue share, by region, 2014 & 2022
5.2 North America
  5.2.1 North America neurology devices market, 2012 - 2022 (USD Million)
5.3 Europe
  5.3.1 Europe neurology devices market, 2012 - 2022 (USD Million)
5.4 Asia Pacific
  5.4.1 Asia Pacific neurology devices market, 2012 - 2022 (USD Million)
5.5 RoW
  5.5.1 RoW neurology devices market, 2012 - 2022 (USD Million)

CHAPTER 6 COMPETITIVE LANDSCAPE

6.1 B. Braun Melsungen AG
  6.1.1 Company Overview
  6.1.2 Financial Performance
  6.1.3 Product Benchmarking
  6.1.4 Strategic Initiatives
6.2 Boston Scientific Corporation
  6.2.1 Company Overview
  6.2.2 Financial Performance
  6.2.3 Product Benchmarking
  6.2.4 Strategic Initiatives
6.3 Covidien PLC
  6.3.1 Company Overview
  6.3.2 Financial Performance
  6.3.3 Product Benchmarking
  6.3.4 Strategic Initiatives
6.4 Integra LifeSciences Holdings Corporation
  6.4.1 Company Overview
  6.4.2 Financial Performance
  6.4.3 Product Benchmarking
  6.4.4 Strategic Initiatives
6.5 Johnson and Johnson
  6.5.1 Company Overview
  6.5.2 Financial Performance
  6.5.3 Product Benchmarking
  6.5.4 Strategic Initiatives
6.6 Medtronic Inc.
  6.6.1 Company Overview
  6.6.2 Financial Performance
  6.6.3 Product Benchmarking
  6.6.4 Strategic Initiatives
6.7 St. Jude Medical, Inc
  6.7.1 Company Overview
  6.7.2 Financial Performance
  6.7.3 Product Benchmarking
  6.7.4 Strategic Initiatives
6.8 Stryker Corporation
  6.8.1 Company Overview
  6.8.2 Financial Performance
  6.8.3 Product Benchmarking
  6.8.4 Strategic Initiatives
6.9 W.L. Gore & Associates, Inc.
  6.9.1 Company Overview
  6.9.2 Financial Performance
  6.9.3 Product Benchmarking
  6.9.4 Strategic Initiatives
6.10 Magstim Co Ltd.
  6.10.1 Company Overview
  6.10.2 Financial Performance
  6.10.3 Product Benchmarking
  6.10.4 Strategic Initiatives


More Publications